Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Day One Biopharmaceuticals (DAWN) Income from Non-Controlling Interests (2022 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Income from Non-Controlling Interests for 4 consecutive years, with $19.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Income from Non-Controlling Interests rose 154.56% to $19.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $145.3 million, a 93.04% increase, with the full-year FY2024 number at $88.4 million, down 53.23% from a year prior.
  • Income from Non-Controlling Interests was $19.7 million for Q3 2025 at Day One Biopharmaceuticals, down from $30.3 million in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of $142.2 million in Q4 2022 to a low of -$36.2 million in Q3 2024.
  • A 4-year average of $40.9 million and a median of $40.9 million in 2023 define the central range for Income from Non-Controlling Interests.
  • Peak YoY movement for Income from Non-Controlling Interests: crashed 178.34% in 2024, then skyrocketed 962.07% in 2025.
  • Day One Biopharmaceuticals' Income from Non-Controlling Interests stood at $142.2 million in 2022, then plummeted by 67.54% to $46.2 million in 2023, then rose by 28.36% to $59.2 million in 2024, then tumbled by 66.7% to $19.7 million in 2025.
  • Per Business Quant, the three most recent readings for DAWN's Income from Non-Controlling Interests are $19.7 million (Q3 2025), $30.3 million (Q2 2025), and $36.0 million (Q1 2025).